Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Ethan Basch, Deborah Schrag, Andrea Denicoff et al.|JNCI Journal of the National Cancer Institute|2014Cited by 1.1k
The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's ExperienceS. Yousuf Zafar, Amy P. Abernethy, Jeffrey Peppercorn et al.|The Oncologist|2013Cited by 1.1k
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Amylou C. Dueck, Ethan Basch, Tito R. Mendoza et al.|JAMA Oncology|2015Cited by 1k
Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective studyMagnus Ekström, David C. Currow, Anna Bornefalk‐Hermansson et al.|BMJ|2014Cited by 298
Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapyMagnus Ekström, David C. Currow, Zainab Ahmadi et al.|Cochrane Database of Systematic Reviews|2016Cited by 99